Abstract 113: A comparative preclinical PET imaging study between [11C]erlotinib and [18F]afatinib

MLA

Egbert F. Smit, et al. “Abstract 113: A Comparative Preclinical PET Imaging Study between [11C]Erlotinib and [18F]Afatinib.” Cancer Research, vol. 74, Oct. 2014, p. 113. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a5b68aa55237a71458b11a727256f595&authtype=sso&custid=ns315887.

APA

Egbert F. Smit, Marijke Stigter-van Walsum, Guus A.M.S. van Dongen, Heiko G. Niessen, Alex J. Poot, Albert D. Windhorst, Paul Slobbe, & Robert C. Schuit. (2014). Abstract 113: A comparative preclinical PET imaging study between [11C]erlotinib and [18F]afatinib. Cancer Research, 74, 113.

Chicago

Egbert F. Smit, Marijke Stigter-van Walsum, Guus A.M.S. van Dongen, Heiko G. Niessen, Alex J. Poot, Albert D. Windhorst, Paul Slobbe, and Robert C. Schuit. 2014. “Abstract 113: A Comparative Preclinical PET Imaging Study between [11C]Erlotinib and [18F]Afatinib.” Cancer Research 74 (October): 113. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a5b68aa55237a71458b11a727256f595&authtype=sso&custid=ns315887.